Compugen (CGEN) Operating Income (2009 - 2026)
Compugen (CGEN) posted quarterly Operating Income of $9.0 million for Q1 2026, up 7.41% year-over-year from $8.4 million in Q1 2025, and down 83.91% on a QoQ basis from $56.0 million in Q4 2025.
Compugen (CGEN) Operating Income (2009 - 2026) Analysis & Trends
Compugen has reported Operating Income for 18 years, with the latest figure at $9.0 million in Q1 2026.
- Operating Income for Q1 2026 came in at $9.0 million, up 7.41% year-over-year; the trailing twelve-month figure through Mar 2026 was $31.9 million (up 313.16% YoY), and the FY2025 annual result was $31.3 million, up 310.37% from the prior year.
- Operating Income eased to $9.0 million in Q1 2026, from $56.0 million in the prior quarter.
- Over five years, Operating Income peaked at $56.0 million in Q4 2025 and troughed at -$30.5 million in Q2 2023.
- A 5-year average of -$218733.3 and a median of -$3.5 million in 2022 frame the typical range for Operating Income.
- The largest YoY upside for Operating Income was 848.94% in 2025 against a maximum downside of 275.56% in 2025.
- A 5-year view of Operating Income shows it stood at -$3.5 million in 2022, then surged by 609.61% to $18.0 million in 2023, then tumbled by 141.61% to -$7.5 million in 2024, then surged by 848.94% to $56.0 million in 2025, then slumped by 83.91% to $9.0 million in 2026.
- Per Business Quant data, the three most recent Operating Income figures were $9.0 million in Q1 2026, $56.0 million in Q4 2025, and -$7.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 493.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 325.05 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,158.03 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 133.12 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 231.44 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.55 Mn |
| 10 | Compugen | 227.88 Mn | 136.13 Mn | 352,000.00 | 9.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.02 Mn |
| Dec 31, 2025 | 56.04 Mn |
| Sep 30, 2025 | -7.89 Mn |
| Jun 30, 2025 | -25.22 Mn |
| Mar 31, 2025 | 8.40 Mn |
| Dec 31, 2024 | -7.48 Mn |
| Sep 30, 2024 | 4.50 Mn |
| Jun 30, 2024 | -20.40 Mn |
| Mar 31, 2024 | 8.49 Mn |
| Dec 31, 2023 | 17.98 Mn |
| Sep 30, 2023 | -10.63 Mn |
| Jun 30, 2023 | -30.48 Mn |
| Mar 31, 2023 | 10.13 Mn |
| Dec 31, 2022 | -3.53 Mn |
| Sep 30, 2022 | -12.21 Mn |
| Dec 31, 2021 | -8.78 Mn |
| Sep 30, 2021 | -6.33 Mn |
| Mar 31, 2021 | -10.26 Mn |
| Dec 31, 2020 | -9.09 Mn |
| Mar 31, 2020 | -7.40 Mn |